Universe Pharmaceuticals (UPC) Accounts Payables (2021 - 2025)
Universe Pharmaceuticals' Accounts Payables history spans 5 years, with the latest figure at $262.6 million for Q3 2025.
- On a quarterly basis, Accounts Payables fell 25.57% to $262.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $262.6 million, a 25.57% decrease, with the full-year FY2025 number at $262.6 million, down 25.57% from a year prior.
- Accounts Payables hit $262.6 million in Q3 2025 for Universe Pharmaceuticals, down from $352.9 million in the prior quarter.
- Over the last five years, Accounts Payables for UPC hit a ceiling of $352.9 million in Q3 2024 and a floor of $3.1 million in Q3 2022.
- Historically, Accounts Payables has averaged $125.7 million across 5 years, with a median of $5.3 million in 2021.
- Biggest five-year swings in Accounts Payables: tumbled 42.09% in 2022 and later soared 7595.36% in 2024.
- Tracing UPC's Accounts Payables over 5 years: stood at $5.3 million in 2021, then tumbled by 42.09% to $3.1 million in 2022, then soared by 49.1% to $4.6 million in 2023, then soared by 7595.36% to $352.9 million in 2024, then decreased by 25.57% to $262.6 million in 2025.
- Business Quant data shows Accounts Payables for UPC at $262.6 million in Q3 2025, $352.9 million in Q3 2024, and $4.6 million in Q3 2023.